The kidney is a major source of the plasma enzyme glutathione peroxidase. We measured plasma glutathione peroxidase activity in 130 patients affected with difFerent renal diseases at various stages, and compared it with the following indices of kidney function: serum creatinine, creatinine clearance, and urinary excretion of a 1 -microglobulin, ß 2 -microglobulin, albumin and N-acetyl-ß-D-glucosaminidase. Plasma glutathione peroxidase activity appeared significantly reduced in most of the renal diseases considered, and showed a significant correlation with most of the renal function indices. Linear discriminant analysis showed that the set of indices composed of plasma glutathione peroxidase activity, serum creatinine and creatinine clearance allowed the best classification of renal diseases. During treatment with the nephrotoxic aminoglycoside, tobramycin, plasma glutathione peroxidase activity showed an early and progressive decrease. We suggest the measurement of plasma glutathione peroxidase activity äs an adjunctive index for the assessment of kidney alterations.
Introduction
In order to assess renal function, a series of laboratory tests that investigate difFerent mechanisms of renal physiology has been proposed. An exhaustive review concerning this topic has been recently published (1) .
The pürpose of these laboratory measürements is mainly to improve the accuracy of the diagnostic process, thereby reducing the necessity for more invasive procedures such äs kidney biopsy. At present, glomerular filtration, urine protein excretion, waten and electrolyte metabolisrn disturbances are investigated, using appropriate laboratory tests. Most of the commonest tests are actually both dependeiit on, and influenced by, the excretory Status of the kidney. In this respect glomerular filtration äs assessed by creatinine clearance may be biased by tubulär mechanisms of excretion, thus reducing the usefulness of this measurement (2) ; on the other hand the ascertainment of tubulär function frorn the excretion of specific urine proteins, such äs microglobulins, may be influenced by their actual protein load on the proximal tubulär cells, thus limiting the specificity of such markers (3) . In this study we present evidence that a plasma enzyme known äs glutathione peroxidase 1 ) ean be used in assessing kidney damage independently from other known indices. Plasma glutathione peroxidase is a selenium-dependent enzyme expressed in human kidney and in some other tissues (4, 5) . Glutathione peroxidase activity is reported to be markedly depressed in chronic renal failure and in dialysed individuals regardless of the selenium Status (6) , which contradicts reports on its relationship to the alimentary selenium supply in healthy individuals (7) . Nevertheless, this index has not yet been evaluated in comparison with other established tests of renal ftmction, and it has not yet been used for the diagnosis of diflferent kidney diseases. In the present paper we discuss the results obtained after measuring plasma glutathione peroxidase together with tests devised to explore either the glomerular filtration rate or the damages to the glomerular and proximal tubular sites of the nephron. We confirm preliminary data (8) and show that plasma glutathione peroxidase can be a suitable index for the differential evaluation of kidney diseases.
Materials and Methods

Patients
One hundred and thirty individuals aged 13-91 years (58.6 ± 18.0, mean ± SD), affected with different types of renal diseases, were studied. Patients were subdivided into seven groups according to their diagnosis (tab. 1).
Samples
Serum and EDTA plasma were obtained from blood withdrawn from fasting individuals in tbe early morning.
Urine samples were from 24-hour collections and from random specimens. ' ' Plasma glutathione peroxidase activity Measurements were performed at 37 °C and at 340 nm on plasma using an automated adaptation of the method proposed by Günzler et al. (9) on an RA-1000 autoanalyser (Bayer). Briefly, terf-butylhydroperoxide 0.12 mmol/1 was used äs Starter in a pH 7.4, 0.1 mol/1 phosphate buffered System containing the following reagents: 20 mmol/1 Na 2 EDTA, 0.2 mmol/I NADPH, l mmol/1 reduced glutathione, 1.25 U/l glutathione reductase (final concentrations); plasma was added at a ratio of 1/50 with respect to the final volume. Catalytic activity concentration was expressed äs U/l, corresponding to 1 ).
Urinary proteins . , -Mücroglobulin, ß 2 Ä microglobulin and albumin were measured on fresh random samples by immunonephelometry on Behring Nephelometer Systems (Behring, Scoppito-L'Aquüa, Italy), using comrnercial polyclonal antiserum and cälibrators (Behring for either ai-microglobulin or albumin, and Biosys Diagnostici, Varedo-Milan, Italy, for ß 2 -microglöbulin) (11) (12) (13) .
N-acetyl-ß-D-glucosaminidase 1 ) was assayed on a Hitachi 704 analyser using a commercial kit (Boehringer Mannheim, Germany) (14) .
Analytical and biological variability of plasma glutathione peroxidase Withiri tun analytical variability was measured on pooled normal plasma by thirty consecutive replicates; between days analytical variability was similarly estimated by assays conducted on the same pooled plasma during thirty consecutive days. Biological variability was calculated on six healthy individuals, three males and three females, aged 22-44. Blood samples were withdrawn at weekly intervals for the period of one month.
Aminoglycoside treatment
Two elderly female patients, aged 88 (case 1) and 99 (case 2) affected with bronchoalveolar infectious disease, were treated with i. m. tobramycin, 200 mg/day for 7 days. Plasma glutathione peroxidase activity, serum creatinine, urinary excretion of albumin and ai-microglobuliii were monitored daily before the administration of the first dose (day 1), then subsequently until day 8.
Statistical methods
Results of the disease groups were compared with the aid of the Wilcoxon rank-surh test for unpaired data, and reciprocal correlations were calculated by linear regression analysis. Linear disĉ riminant analysis, a multivariate method, was used to identify the set of laboratory tests more suitable for the classification of the kidney diseases.
Results
Renal function indices
Data of the indices of renal function in the chosen kidney diseases are reported im table 2. Plasma glutathione peroxidase activity appeared to be significantly reduced in the following diseases: Bartter's syndrome, chronic renal failure, prerenal azotaemia (p < 0.001) and in renal transplants (p < 0.05). Creatinine clearance was significantly decreased (p < 0.001) in all but the renal glycosuria group; serum. creatinine levels were signifieantly enhanced im renal glycosuria, Bartter's syndrome, chronic renal failure, renal transplants (p < 0.001) and in the glomerulonephritis and prerenal azotaemia groups (p < 0.05); urinary aj-microglobülin excretion was significantly increased (p < 0.00J) in all the groups, except (12) 87 (8) 263 (64) 98 (7) 478 (46) 219 (52) 162 (34) 88 ( the renal glycosuria and rcnal transplants groups; urinary ß2-microglobulin excretion was increascd in Bartter's syndrome, tubulointerstitial disease from aminoglycosides, chronic renal failure (p < 0.001), in prerenal azotaemia (p < 0.01) and in the glomerulonephritis and renal glycosuria groups (p < 0.05) (renal transplant group not evaluated); urinary N-acetyl-ß-D-glucosaminidase activity was significantly enhanced in glomerulonephritis, tubulointerstitial disease from aminoglycosides, chronic renal failure (p < 0.001) and in the prerenal azotaemia groups (p < 0.05) (renal transplant group not evluated); finally, urinary albumin excretion was significantly increased in tubulointerstitial disease from aminoglycosides, chronic renal failure, renal transplants (p < 0.001) and in the prerenal azotaemia (p < 0.01) groups.
Plasma glutathione peroxidase activity showed a good correlation with serum creatinine (r =-0.61, p < 0.001), creatinine clearance (r = 0.56, p < 0.001), ,-microglobulin (r = -0.43, p < 0.001) and, to a minor extent, with ß 2 -microglobulin (r = -0.28, p < 0.01) and albumin (r = -0.19, p < 0.05) urinary excretion (flg. 1).
Linear discriminant analysis
Linear discriminant analysis showed that the set of rneasurements consisting of plasma glutathione peroxidase activity, creatinine clearance and serum creatinine allowcd the best classification of Bartfer's syndrome and chronic renal failure groups (43% and 85% respectivcly). Moreover, this set of analyses failed to classify the prerenal azotaemia group (0%). In other sets of indices, the control group was correctly classified only when plasma glutathione peroxidase was includcd (the best classification being 80%, the worst one 35%, with and without the inclusion of plasma glutathione peroxidase, respectively).
Plasma glutathione peroxidase analytical and biological variability
Within run and between days and analytical variability (CV a %) were 2.16 and 4.02, respectively. Mean biological variability (CVj%) in a group of six healthy individuals was 6.02. Figure 2 shows the daily data for plasma glutathione peroxidase activity, serum creatinine levels, and a r microglobulin and albumin urinary excretion in two patients during one weck of treatment with tobramycin.
Aminoglycoside treatment
Case l (flg. 2a) exhibited a marked decrease of glutathione peroxidase activity äs early äs day 2, although serum creatinine levels were in the lower ränge of the reference values. Urinary albumin excretion, already el- evated at the start of the treatment (day 1), markedly increased only after three days of treatment (day 4). In case 2 ( fig. 2b) , the starting value of plasma glutathione peroxidase was already low (95 U/l) and the value of albuminuria was above the upper normal reference ränge (4.06 g/mol creatinine). On day 5, while serum creati-°n ine values were still within the normal reference ränge, plasma glutathione peroxidase activity showed a further decrease. In any case, although no marked alterations of glomentlar filtration rate were found, it was noticed that plasma glutathione peroxidase activity tended to decrease concomitant with an increase of serum creatinine levels. Enhänced -urinary albumin excretion was an early sign of the effect of therdrug on the kidney. ; urinary a r microfunction tests. Graph a refers to case l, which shows a more pro-globulin g/mol creatinine V; urinary albumin g/mol creatinine V. nounced decrease of plasma glutathione peroxidase activity, while Asterisks mark significant differences for plasma glutathione pergraph b represents a milder condition (case 2); plasma glutathione oxidase.
Discussion
The activity of the enzyme, plasma glutathione peroxidase, was significantly reduced in chronic renal failure (p < 0.001) and in some of the kidney diseases studied, namely Bartter's syndrome, prerenal azotaemia (p < 0,001) and also in renal transplants (p < 0.05), irrespective of the serum creatinine levels. A number of enzyme activities has been proposed for evaluating renal tubular damage, including N-acetyl-ß-£>-glucosaminidase, -glutamyltransferase, ribonuclease (15) and glutathione-S-transferase (16) . However, these have to be measured in urine samples, since they are excreted in cases of proximal tubular damage, involving either brush border or lysosomes. In contrast, plasma glutathione peroxidase activity is assayed in plasma and seems to reflect the amount of the enzyme synthesized by the kidney. The functional role of plasma glutathione peroxidase has not been fully elucidated, although it is thought to have a protective function against lipoprotein peroxidation, mainly by reducing phosphatidylcholine hydroperoxide (17) . Also, a locäl mechanism against renal glomeralar injury by free radicals has been attributed to plasma glutathione peroxidase, similar to that of other scavenger molecules (18) (19) . We previously demonstrated that by increasing the oral intake.of Se, a known trace element essentiäl for plasma glutathione peroxidase syiithesis, the glomerular filtration rate could be stably improved (20) . Low plasma glutathione peroxidase activities have been found in chronic renal failure patients and this could account for the accelerated atherosclerotic process peeuliar to these individuals (21) . The kidney is in fact the most important site of synthesis of plasma glutathione peroxidase (4) and the metäbolism of reduced glutathione is very aetive in this organ (22) . Therefore, the measurement of plasma glutathione peroxidase activity can be expected to be a sensitive index of kidney function, unaffected by the preanalytical errors of urine collection. Actually, plasma glutathione peroxidase activity was significantly correlated with the most effective laboratory indices of kidney function, namely serum creatinine, creatinine clearance, armicroglobulin, ß 2 -microglobulin and albumin urinary excretion ( fig. 1 ). Although the plasma glutathione peroxidase gene seems to be expressed in other human tissues besides the kidney (5), the association of low enzyme activity in the plasma of patients with some kidney disorders, along with other laboratory indicators of renal function, suggests that the kidney is a main determinant of the levels of plasma glutathione peroxidase. We used a multivariate statistical method (linear discriminant analysis) to evaluate the contribution made by plasma glutathione peroxidase data to a set of related measurements of renal function commonly performed. When individuals belonging to previously defined kidney diseases were ägain classified using the discriminant function obtained by the above mentioned statistical procedure, the following conclusions could be drawn: 1) the set composed of plasma glutathione peroxidase plus creatinine clearance and serum creatinine allowed the most correct classification ofBartter's syndrome and chronic renal failure, compared with all other sets of laboratory variables;
2) the same set was unable to classify the prerenal azotaemia group: this fact appears to reinforce the conclusion that plasma glutathione peroxidase contributes to the classification of primary kidney damage;
3) aj-microglobulin and, above all, ß 2 -microglobulin excretion did not increase the correctness of the classifi-cation when plasma glutathione peroxidase was not considered in the statistical procedure. Therefore, in order to discriminate more extensively between kidney diseases, we suggest that the measurement of plasma glutathione peroxidase activity should be complemented by the determination of serum creatinine and creatinine clearance. However, we emphasize that in observing the excretion pattems, the natural progression of the disease must be considered; in fact, atrophy and degeneration, äs well äs regeneration and recovery of proximal tubules and loss of glomerular barrier function of damaged kidneys, may occur simultaneously (23) . Moreover, äs plasma glutathione peroxidase seems to be directly synthesised by the nephron, its activity might be representative of the residual functional mass of the kidney, unaffected by mechanisms of either filtration or excretion. Alternatively, the perfiision of the kidney may determine glutathione peroxidase plasma levels; the latter being significantly increased in renal glycosuria,, but decreased in the renal diseases mentioned above. We therefore maintain that plasma glutathione peroxidase should be considered a unique index of renal fimction, different fronn all laboratory quantities.
The narrow biological variability shown by plasma glutathione peroxidase activity means that this enzyme activity is a suitable quantity for monitoring changes in kidney function (24) . In fact, plasma glutathione peroxidase activity did progessively decrease during the aminoglycoside treatment, a.type of drug known to cause a renal functional deraiigement in up to 36 percent of patients, predorninantly restricted to the proximal tubule, where the aminoglycosides accumulate (25) . Indeed, differences between two successive resülts greater than the critieal difference were registered on several occasions ( fig. 2 ). This observation gives further biological plaüsibility to plasma glutathione peroxidase äs an index of renal function assessment. Moreover, the decrease of plasma glutathione peroxidase activity dür-ing aminoglycoside treatment preceded the increase of serum creatinine; this is similar to the excretion of üri-nary ß2-microglobulin, which preceded the decrease in glomerular filtration rate (26) . In conclusion we consider the measurement of plasma glutathione peroxidäse activity to be ä new and important adjunct in the diagnosis of renal diseases, especiälly when more Information is needed on tubular-interstitial alterations. Further investigations should be encouraged in this field.
